Research ArticleExperimental Studies

DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines

VERONIKA LANDGRAF, MATTHIAS GRIESSMANN, JEANETTE ROLLER, CHRISTINE POLEDNIK and MARIANNE SCHMIDT
Anticancer Research July 2019, 39 (7) 3633-3639; DOI: https://doi.org/10.21873/anticanres.13511

Article Information

vol. 39 no. 7 3633-3639
DOI 
https://doi.org/10.21873/anticanres.13511
PubMed 
31262889
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 22, 2019
  • Revision received June 14, 2019
  • Accepted June 18, 2019
  • Published online July 1, 2019.
Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. VERONIKA LANDGRAF,
  2. MATTHIAS GRIESSMANN,
  3. JEANETTE ROLLER,
  4. CHRISTINE POLEDNIK and
  5. MARIANNE SCHMIDT⇑
  1. Department of Otorhinolaryngology, University of Wuerzburg, Wuerzburg, Germany
  1. Correspondence to: Marianne Schmidt, Department of Otorhinolaryngology, University of Wuerzburg, Josef-Schneider-Straße 11, D-97080 Wuerzburg, Germany. Tel: +49 93120121365, Fax: +49 93120121166, e-mail: Schmidt_m2{at}ukw.de
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines
VERONIKA LANDGRAF, MATTHIAS GRIESSMANN, JEANETTE ROLLER, CHRISTINE POLEDNIK, MARIANNE SCHMIDT
Anticancer Research Jul 2019, 39 (7) 3633-3639; DOI: 10.21873/anticanres.13511
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords